医学
慢性鼻-鼻窦炎
鼻腔给药
皮质类固醇
内科学
鼻窦炎
鼻子
抗生素
呼吸道疾病
不利影响
药物治疗
抗菌剂
糖皮质激素
药理学
临床疗效
临床试验
免疫学
作者
Hu Li,Houyong Li,Lu Yang,Changqing Zhao,Guolin Tan,Haitong Li,Gang Zheng,Shaoqing Yu,Lifeng Xie,Yuehui Liu,Xicheng Song,Quangui Wang,Victor W.-C. Chang,Jiqiao Zhang,Dan Zhang,Yurong Gu,Dehui Wang
标识
DOI:10.1016/j.intimp.2025.115341
摘要
Intranasal corticosteroid combined with mucoactive drugs therapy (budesonide-256 μg/day combined with ELP enteric capsules-0.8 g/day) has the potential to improve subjective symptoms and promote physiological recovery for adult patients with CRS, especially for smokers.
科研通智能强力驱动
Strongly Powered by AbleSci AI